Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02513472 |
|---|---|
| Brief Title: | Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC) (ENHANCE-1) |
| First Submitted : | July 29, 2015 |
| First Submitted that Met QC Criteria : | July 30, 2015 |
| First Posted : | July 31, 2015 (Estimate) |
| Results First Submitted : | July 29, 2020 |
| Results First Submitted that Met QC Criteria : | July 29, 2020 |
| Results First Posted : | August 14, 2020 |
| Last Update Submitted that Met QC Criteria : | July 29, 2020 |
| Last Update Posted : | August 14, 2020 |